Covid: Zydus initiates phase I, II clinical trials

India's second vaccine under development, Ahmedabad based Zydus Cadila's novel ZyCoV-D has now received ready approvals from the authorities to start phase I and II of clinical trials. The pharma major has proceeded to start with the experimental dosing.